Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes

Vaccine. 2000 Jan 31;18(14):1289-93. doi: 10.1016/s0264-410x(99)00405-3.

Abstract

The Ring-Infected Erythrocyte Surface Antigen (Pf155/RESA) sequence was chemically synthesized in fifty four 20-mer sequential peptides, covering the entire protein, each of which was tested in erythrocyte binding assays. Peptides 6671 and 6673, corresponding to residues 141-160 and 181-200, respectively, presented a high specific binding activity to erythrocytes with affinity constants of 190 nM and 105 nM respectively. Their binding was sensitive to previous enzymatic treatment of erythrocytes. A region of peptide 6673 has been identified, very recently, as a B-cell epitope, target of neutralizing antibodies (Siddique AB, Iqbal J, Ahlborg N, Wâhlin FB, Perlmann P, Berzins K. Antibodies to nonrepeat sequences of antigen Pf155/RESA of Plasmodium falciparum inhibit parasite growth in vitro. Parasitol Res 1998;84:485-91). The critical residues for erythrocyte binding for peptide 6671 (MTDVNRYRYSNNYEAIPHIS) and for peptide 6673 (LGRSGGDIIKKMQTLWDEIM) were recognized. Based on these data, the presence of five functional regions of RESA is postulated.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Surface / metabolism
  • Erythrocytes / metabolism*
  • Erythrocytes / parasitology
  • Humans
  • Molecular Sequence Data
  • Peptides / chemical synthesis
  • Peptides / metabolism
  • Plasmodium falciparum / metabolism*
  • Protozoan Proteins / metabolism*

Substances

  • Antigens, Surface
  • Peptides
  • Protozoan Proteins
  • ring-infected erythrocyte surface antigen (RESA), Plasmodium falciparum